Immunoprecise Antibodies Ltd Capital Reinvestment Ratio
Immunoprecise Antibodies Ltd capital reinvestment ratio. Immunoprecise Antibodies Ltd (IPA) has a Capital Reinvestment Ratio of 1.62x as of October 2020, meaning it reinvests 2% of its operating cash flow ($440.23K) in capital expenditures ($715.21K). Check Immunoprecise Antibodies Ltd (IPA) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Immunoprecise Antibodies Ltd (2016–2016)
Capital reinvestment ratio of Immunoprecise Antibodies Ltd from 2016 to 2016. This chart tracks Immunoprecise Antibodies Ltd's Capital Reinvestment Ratio across 1 annual periods. Also explore IPA net assets growth trend to track the company's year-over-year net asset growth rate.
Immunoprecise Antibodies Ltd Capital Reinvestment Ratio by Year (2016–2016)
Immunoprecise Antibodies Ltd capital reinvestment ratio by year from 2016 to 2016. For the full cash flow conversion analysis, see Immunoprecise Antibodies Ltd cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2016 | 0.06x | $284.09K | $17.48K | — |